Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Patient Education
Share your love
Stem Cell Breakthrough Restores Vision in LSCD Patients
In a groundbreaking achievement, researchers from Osaka University in Japan have successfully conducted the first human trial using induced pluripotent stem-cell-derived corneal epithelium to treat limbal stem cell deficiency (LSCD). This innovative approach marks a significant advancement in vision restoration…
Bimekizumab Reduces Uveitis Incidence in axSpA Patients
The study led by Matthew A. Brown, Genomics England, London, United Kingdom, and Martin Rudwaleit, Klinikum Bielefeld, University of Bielefeld, Bielefeld, Germany. Patients with axial spondyloarthritis (axSpA) treated with bimekizumab exhibited a markedly lower incidence of uveitis compared to those receiving…
U.S. Glaucoma Prevalence and Risk Factors Study
A new study titled “Prevalence of Glaucoma Among US Adults in 2022”, published in JAMA Ophthalmology, has revealed updated statistics on the prevalence of glaucoma in the United States. The research shows that approximately 4.22 million U.S. adults (1.62% of…
Rethinking Dry Eye Diagnosis in Resistant Patients
Many conditions can mimic dry eye disease (DED), leading to misdiagnoses and ineffective treatments, warned Vatinee Y. Bunya, MD, MSCE, during a presentation at Cornea Subspecialty Day at the American Academy of Ophthalmology meeting. Dr. Bunya emphasized the need for…
Ocular Side Effects Linked to Ovarian Cancer Drug
A recent study presented at the American Academy of Ophthalmology (AAO) meeting in Chicago has identified significant ocular side effects associated with mirvetuximab soravtansine (Elahere), a drug approved for ovarian cancer treatment. The research, conducted by Stanford University, highlights the…
New Imaging Boosts Geographic Atrophy Diagnosis
At the 2024 American Academy of Ophthalmology (AAO) meeting in Chicago, Dr. SriniVas R. Sadda discussed the evolving landscape of imaging technologies for diagnosing geographic atrophy (GA). While traditional methods like flash color fundus photography have been the gold standard…
SLT Beats Medications in Glaucoma – AAO 2024
A recent retrospective analysis of the Laser in Glaucoma and Ocular Hypertension (LiGHT) trial data demonstrated that selective laser trabeculoplasty (SLT) as a first-line treatment significantly outperforms glaucoma medications in reducing the rate of visual field (VF) loss. This study,…
Reducing the Carbon Footprint of Intravitreal Injections
Adopting specific treatment protocols, minimizing travel for patients and staff, and reducing unnecessary use of personal protective equipment (PPE) can significantly decrease the carbon footprint of intravitreal injections. This topic was discussed in detail by Redmer van Leeuwen, MD, PhD,…
Study: Aromatherapy Eases Post-Surgery Anxiety and Pain
A recent study suggests that aromatherapy may effectively reduce postoperative anxiety and pain in patients undergoing oculoplastic procedures under monitored anesthetic sedation. Published in Ophthalmic Plastic and Reconstructive Surgery, this randomized controlled trial highlights the potential of aromatherapy as an…
Study Links Socioeconomics to Severe Retinal Detachment
A recent study indicates that patients living in socioeconomically deprived neighborhoods are more likely to present with severe rhegmatogenous retinal detachment (RRD), a serious eye condition that can lead to vision loss if not treated promptly. Adverse social determinants of…